Duchenne’s Patient Ryan Benton Discusses His Experience with Stem Cell Therapy

Ryan Benton is the first patient in the United States to receive human umbilical cord-derived mesenchymal stem cell therapy for Duchenne’s muscular dystrophy. The US FDA granted Ryan this trial under compassionate use. Ryan first began treatments at the Stem Cell Institute in Panama before being able to receive treatments in his hometown of Wichita, Kansas.

2015-02-17T00:59:43+00:00 February 17th, 2015|Duchenne's muscular dystrophy, News, Stem Cell Research|